GB9618634D0 - Anti cancer drugs - Google Patents
Anti cancer drugsInfo
- Publication number
- GB9618634D0 GB9618634D0 GBGB9618634.1A GB9618634A GB9618634D0 GB 9618634 D0 GB9618634 D0 GB 9618634D0 GB 9618634 A GB9618634 A GB 9618634A GB 9618634 D0 GB9618634 D0 GB 9618634D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- cancer drugs
- anti cancer
- drugs
- cancer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9618634.1A GB9618634D0 (en) | 1996-09-06 | 1996-09-06 | Anti cancer drugs |
PCT/GB1997/002410 WO1998009668A2 (en) | 1996-09-06 | 1997-09-08 | Use of amphiphiles as phosphatidyl choline synthesis inhibitors |
AU41285/97A AU4128597A (en) | 1996-09-06 | 1997-09-08 | Phosphatidylcholine synthesis inhibitors |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9618634.1A GB9618634D0 (en) | 1996-09-06 | 1996-09-06 | Anti cancer drugs |
Publications (1)
Publication Number | Publication Date |
---|---|
GB9618634D0 true GB9618634D0 (en) | 1996-10-16 |
Family
ID=10799530
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GBGB9618634.1A Pending GB9618634D0 (en) | 1996-09-06 | 1996-09-06 | Anti cancer drugs |
Country Status (3)
Country | Link |
---|---|
AU (1) | AU4128597A (en) |
GB (1) | GB9618634D0 (en) |
WO (1) | WO1998009668A2 (en) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6312662B1 (en) | 1998-03-06 | 2001-11-06 | Metabasis Therapeutics, Inc. | Prodrugs phosphorus-containing compounds |
EP1634886A3 (en) * | 1999-03-05 | 2006-03-29 | Metabasis Therapeutics, Inc. | Novel phosphorus-containing prodrug |
US7205404B1 (en) | 1999-03-05 | 2007-04-17 | Metabasis Therapeutics, Inc. | Phosphorus-containing prodrugs |
WO2000052015A2 (en) * | 1999-03-05 | 2000-09-08 | Metabasis Therapeutics, Inc. | Novel phosphorus-containing prodrugs |
AU7361400A (en) | 1999-09-08 | 2001-04-10 | Metabasis Therapeutics, Inc. | Prodrugs for liver specific drug delivery |
AU776185B2 (en) * | 2000-02-14 | 2004-09-02 | Wako Pure Chemical Industries, Ltd. | A method for preparation of a quaternary ammonium salt |
EP1263752B1 (en) * | 2000-03-17 | 2007-12-05 | The University Of Tennessee Research Corporation | Lpa receptor agonists and antagonists and methods of use |
FR2818646B1 (en) * | 2000-12-22 | 2006-06-23 | Oreal | NOVEL C-GLYCOSIDE DERIVATIVES AND USE |
FR2818547B1 (en) | 2000-12-22 | 2006-11-17 | Oreal | NOVEL C-GLYCOSIDE DERIVATIVES AND USE |
EP3105238A4 (en) | 2014-02-13 | 2017-11-08 | Ligand Pharmaceuticals, Inc. | Prodrug compounds and their uses |
EP3164136A4 (en) | 2014-07-02 | 2018-04-04 | Ligand Pharmaceuticals, Inc. | Prodrug compounds and uses therof |
CN111788196A (en) | 2018-01-09 | 2020-10-16 | 配体药物公司 | Acetal compounds and their therapeutic use |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5984824A (en) * | 1982-11-08 | 1984-05-16 | Takeda Chem Ind Ltd | Antitumor agent |
JPH0720860B2 (en) * | 1984-02-24 | 1995-03-08 | 理化学研究所 | Anti-cancer drug |
-
1996
- 1996-09-06 GB GBGB9618634.1A patent/GB9618634D0/en active Pending
-
1997
- 1997-09-08 AU AU41285/97A patent/AU4128597A/en not_active Abandoned
- 1997-09-08 WO PCT/GB1997/002410 patent/WO1998009668A2/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO1998009668A2 (en) | 1998-03-12 |
AU4128597A (en) | 1998-03-26 |
WO1998009668A3 (en) | 1998-06-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PL319342A1 (en) | Drugs | |
PL340337A1 (en) | Drugs | |
AU1958897A (en) | Egf-genistein conjugates for the treatment of cancer | |
GB9606805D0 (en) | Medicaments | |
GB9602080D0 (en) | Pharmaceutical compounds | |
HUP9901674A3 (en) | New pharmaceutical combination | |
AP2002002661A0 (en) | Combination therapy for oesteoporosis | |
GB9609976D0 (en) | Pharmaceutical compounds | |
GB9618634D0 (en) | Anti cancer drugs | |
EP0934447A4 (en) | Integrated armor system | |
GB9621789D0 (en) | Pharmaceutical compounds | |
GB9509572D0 (en) | Cancer therapy | |
GB9805877D0 (en) | Cancer | |
GB9611947D0 (en) | Medicaments | |
GB9618974D0 (en) | Medicaments | |
GB9605293D0 (en) | Medicaments | |
EP0923564A4 (en) | Pharmaceutical compounds | |
ZA979329B (en) | Pharmaceutical compounds | |
GB9620350D0 (en) | Cancer vaccine | |
GB9703633D0 (en) | Cancer therapy | |
GB9626151D0 (en) | Pharmaceutical compounds | |
GB9611167D0 (en) | Medicaments | |
GB9613096D0 (en) | Medicaments | |
GB9727347D0 (en) | Cancer | |
IL120901A0 (en) | Cancer therapy |